Comparison of Cystatin C and Creatinine in the Assessment of Measured Kidney Function during Critical IllnessShow others and affiliations
2023 (English)In: American Society of Nephrology. Clinical Journal, ISSN 1555-9041, E-ISSN 1555-905X, Vol. 18, no 8, p. 997-1005Article in journal (Refereed) Epub ahead of print
Abstract [en]
Background: Incomplete recovery of kidney function is an important adverse outcome in survivors of critical illness. However, unlike eGFR creatinine, eGFR cystatin C is not confounded by muscle loss and may improve identification of persistent kidney dysfunction.
Methods: To assess kidney function during prolonged critical illness we enrolled 38 mechanically ventilated patients with expected length of stay of >72h near admission to ICU in a single academic medical center. We assessed sequential kidney function using creatinine, cystatin C, and iohexol clearance measurements. The primary outcome was difference between eGFR creatinine and eGFR cystatin C at ICU discharge using Bayesian regression modelling. We simultaneously measured muscle mass by ultrasound of rectus femoris to assess the confounding effect on serum creatinine generation.
Results: Longer length of ICU stay was associated with greater difference between eGFR creatinine and eGFR cystatin C at a predicted rate of 2 ml/min/1.73m2/day (95% confidence interval 1-2). By ICU discharge the posterior mean difference between creatinine and cystatin C eGFR was 33 ml/min/1.73m2 (95% credible interval 24-42). In 27 patients with iohexol clearance measured close to ICU discharge, eGFR creatinine was on average 2-fold greater than the iohexol gold-standard, posterior mean difference 59 ml/min/1.73m2 (95% credible interval 49-69). The posterior mean for eGFR cystatin C suggested a 22 ml/min/1.73m2 (95% credible interval 13-31) overestimation of measured GFR. Each day in ICU resulted in a predicted 2% (95%CI 1-3%) decrease in muscle area. Change in creatinine-to-cystatin C ratio showed good longitudinal, repeated measures correlation with muscle loss, R=0.61 (95% confidence interval, 0.50-0.72).
Conclusions: eGFR creatinine systematically over-estimated kidney function after prolonged critical illness. Cystatin C better estimated true kidney function as it appeared unaffected by the muscle loss of prolonged critical illness.
Place, publisher, year, edition, pages
Ovid Technologies (Wolters Kluwer Health) , 2023. Vol. 18, no 8, p. 997-1005
National Category
Anesthesiology and Intensive Care
Identifiers
URN: urn:nbn:se:uu:diva-502998DOI: 10.2215/CJN.0000000000000203ISI: 001044473000006PubMedID: 37256861OAI: oai:DiVA.org:uu-502998DiVA, id: diva2:1761387
2023-06-012023-06-012023-09-04Bibliographically approved